Susquehanna International Group, LLP Aura Biosciences, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 57,384 shares of AURA stock, worth $337,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,384
Previous 27,341
109.88%
Holding current value
$337,991
Previous $224,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$40.8 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$28.7 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$19.6 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$17.9 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$17.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $172M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...